-
-
-
-
-
-
-
Guardant Health (GH) Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
-
-
-
-
-
-
-
SAB Biotherapeutics (SABS) Announces FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
-
-
-
-
-
-
-
ATARA Biotherapeutics (ATRA) Submits Tabelecleucel BLA for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
-
-
-
-
-
-
-
ANI Pharma (ANIP) Launches Kionex Suspension
-
-
-
-
-
-
-
Analysts weigh in on FDA's approval for Amgen's (AMGN) small cell cancer drug
-
-
-
-
-
-
-
Carisma Therapeutics (CARM) Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
-
-
-
-
-
-
-
Arvinas (ARVN) and Pfizer (PFE) Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant with Palbociclib
-
67,118 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.